158 related articles for article (PubMed ID: 23154206)
21. Wilms' tumor in the adult--report of a case and review of the literature.
Tawil A; Cox JN; Roth AD; Briner J; Droz JP; Remadi S
Pathol Res Pract; 1999; 195(2):105-11; discussion 113-4. PubMed ID: 10093830
[TBL] [Abstract][Full Text] [Related]
22. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
23. Wilms' tumor 1991. Clinical evaluation and treatment.
Exelby PR
Urol Clin North Am; 1991 Aug; 18(3):589-97. PubMed ID: 1652172
[TBL] [Abstract][Full Text] [Related]
24. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
[TBL] [Abstract][Full Text] [Related]
25. Bilateral Wilms' tumors: a single-center experience with 19 cases.
Millar AJ; Davidson A; Rode H; Numanoglu A; Hartley PS; Daubenton JD; Desai F
J Pediatr Surg; 2005 Aug; 40(8):1289-94. PubMed ID: 16080934
[TBL] [Abstract][Full Text] [Related]
26. Late recurrence in children with Wilms' tumor.
Büyükpamukçu M; Köksal Y; Varan A; Atahan L; Cağlar M; Akyüz C; Kutluk T; Büyükpamukçu N
Turk J Pediatr; 2007; 49(2):226-30. PubMed ID: 17907529
[TBL] [Abstract][Full Text] [Related]
27. Improved survival of children with wilms tumor.
Kutluk T; Varan A; Büyükpamukçu N; Atahan L; Cağlar M; Akyüz C; Büyükpamukçu M
J Pediatr Hematol Oncol; 2006 Jul; 28(7):423-6. PubMed ID: 16825987
[TBL] [Abstract][Full Text] [Related]
28. Nephroblastoma: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.
Camassei FD; Arancia G; Cianfriglia M; Bosman C; Francalanci P; Ravà L; Jenkner A; Donfrancesco A; Boldrini R
Am J Clin Pathol; 2002 Mar; 117(3):484-90. PubMed ID: 11888090
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors.
Rakheja D; Khokhar S; Mitui M; Cost NG
Pediatr Dev Pathol; 2012; 15(4):286-92. PubMed ID: 22483234
[TBL] [Abstract][Full Text] [Related]
30. [Wilms' tumor. Its multidisciplinary management].
Rivera Luna R; Martínez Guerra G; Ruano Aguilar J; Cárdenas Cardoz R; Lanche Guevara T
Gac Med Mex; 1992; 128(2):97-104; discussion 104-5. PubMed ID: 1338780
[TBL] [Abstract][Full Text] [Related]
31. [Wilms tumor. Results of treatment in 14 cases (author's transl)].
Bezanilla JL; González-Casaseca T; González Landa G; Gimeno Alfós L; Vilanova J; Navajas A
An Esp Pediatr; 1982 Feb; 16(2):109-18. PubMed ID: 6282160
[TBL] [Abstract][Full Text] [Related]
32. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Green DM; Breslow NE; Evans I; Moksness J; D'Angio GJ
Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
[TBL] [Abstract][Full Text] [Related]
34. Pathological review of Wilms tumor nephrectomy specimens and potential implications for nephron sparing surgery in Wilms tumor.
Cost NG; Lubahn JD; Granberg CF; Sagalowsky AI; Wickiser JE; Gargollo PC; Baker LA; Margulis V; Rakheja D
J Urol; 2012 Oct; 188(4 Suppl):1506-10. PubMed ID: 22910241
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemical evaluation of the percentage of proliferating neoplastic cells of Wilms' tumor in children by means of the MIB-1 monoclonal antibody].
Juszkiewicz P
Ann Acad Med Stetin; 1997; 43():113-27. PubMed ID: 9471911
[TBL] [Abstract][Full Text] [Related]
36. Alpha-fetoprotein producing tumor cells in children with Wilms' tumor.
Kesik V; Ozcan A; Sari E; Guven A; Kismet E; Koseoglu V
Fetal Pediatr Pathol; 2010; 29(3):127-32. PubMed ID: 20450265
[TBL] [Abstract][Full Text] [Related]
37. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
[TBL] [Abstract][Full Text] [Related]
39. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
[TBL] [Abstract][Full Text] [Related]
40. Significance of B7-H1 overexpression in kidney cancer.
Thompson RH; Kwon ED
Clin Genitourin Cancer; 2006 Dec; 5(3):206-11. PubMed ID: 17239274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
